Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (341-350 of 345) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 345 results.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Plos Genetics|April 5, 2013
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritisJing Cui, Eli A Stahl, Saedis Saevarsdottir, et al.
Nature Communications|June 10, 2023
Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethalityAsmundur Oddsson, Patrick Sulem, Gardar Sveinbjornsson, et al.
Nature Communications|July 3, 2023
Publisher Correction: Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethalityAsmundur Oddsson, Patrick Sulem, Gardar Sveinbjornsson, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subsetSaedis Saevarsdottir, Lilja Stefansdottir, Patrick Sulem, et al.
Pageof 35

Showing results (341-350 of 345) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 345 results.
Annals of the Rheumatic Diseases|March 13, 2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 updateJosef S Smolen, Christopher J Edwards, Victoria Konzett, et al.
Plos Genetics|April 5, 2013
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritisJing Cui, Eli A Stahl, Saedis Saevarsdottir, et al.
Nature Communications|June 10, 2023
Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethalityAsmundur Oddsson, Patrick Sulem, Gardar Sveinbjornsson, et al.
Nature Communications|July 3, 2023
Publisher Correction: Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethalityAsmundur Oddsson, Patrick Sulem, Gardar Sveinbjornsson, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subsetSaedis Saevarsdottir, Lilja Stefansdottir, Patrick Sulem, et al.
Pageof 35